The company predicts approximately $3.75 billion in GLP-1RA sales in 2025
Medication concentrations, syringe types, and prescribed doses can vary
SD, 15 mmHg s) after administration of GLP1
Remember that medication adjustments should only be made under medical supervisiondo not stop or alter your GLP-1 therapy without consulting your prescriber, as this may affect your diabetes control or weight management goals
Extensive clinical research has shown that these medications are effective for sustained weight loss, improved blood sugar control, and a reduced risk of heart-related complications, especially for those with a history of diabetes or cardiovascular disease
If symptoms worsen or are accompanied by fever, dehydration, or abdominal pain, stop using them and contact your healthcare provider